Toyokawa, Gouji <br/><br/>
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.  [electronic resource] 

 -  International journal of clinical oncology  Aug 2014 
 - 601-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1437-7772 
<br/><br/><label>Standard No.: </label>10.1007/s10147-013-0619-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Asbestos--toxicity<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Drug-Related Side Effects and Adverse Reactions--classification<br/>Female<br/>Glutamates--administration & dosage<br/>Guanine--administration & dosage<br/>Humans<br/>Lung Neoplasms--chemically induced<br/>Male<br/>Mesothelioma--chemically induced<br/>Mesothelioma, Malignant<br/>Middle Aged<br/>Neoplasm Staging<br/>Pemetrexed<br/>Pleural Neoplasms--chemically induced<br/>Vinblastine--administration & dosage<br/>Vinorelbine<br/>Gemcitabine